ZappRx Hires Industry Leader to Drive Commercial Growth
BOSTON, April 27, 2016 /PRNewswire/ -- ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing efficient patient access to therapy, today announced the hiring of Lorrie Carr as Chief Commercial Officer. Carr previously served as Divisional VP, Enterprise Specialty Sales & Product Management at Walgreens and has held leadership roles in Global Market Access, Sales and Marketing within pharmaceutical companies Millennium Pharmaceuticals (now Takeda Oncology) and Schering-Plough (now Merck).
In this newly-created role, Carr will lead the company's commercialization efforts as it launches and expands its platform for prescribing and managing specialty drugs into multiple specialty therapeutic areas.
"Lorrie is joining ZappRx at the perfect time as we initiate the launch of our platform within multiple specialty categories and deepen our data footprint," said Zoë Barry, Founder and CEO of ZappRx. "Her expertise in the biopharmaceutical and specialty pharmacy markets will be essential as we expand our relationships and integrations with specialty pharmacies and other industry partners."
U.S. spending on prescription drugs is projected to reach $400B by the year 2020. Specialty drugs, represent less than 2% of prescriptions written but account for almost 40% of drug spending. The process of getting a drug from prescription to patient is cumbersome for all key stakeholders and ultimately delays patient access to critical therapy. Existing attempts to improve upon this process remain largely manual, fragmented, and suffer from poor provider adoption.
"I am joining ZappRx at a time when the specialty pharmaceutical industry is at a critical inflection point," said Carr. "Both the number of available therapies and the costs of these drugs have increased significantly over the last several years. Yet drug manufacturers and other stakeholders lack the real-time, clinical data necessary to measure and improve the fulfillment process, sales performance, and outcomes. ZappRx is taking an innovative approach to improving patient access to specialty therapy while generating critical information for manufacturers and payers."
About ZappRx
ZappRx is modernizing and simplifying the way specialty medications are managed. The company provides a secure, collaborative online platform that allows patients, physicians and pharmacists to work together to improve patients' access to treatment, delivering medicine faster, with fewer hassles and greater transparency. ZappRx is on the web at ZappRx.com. Follow ZappRx on Twitter at twitter.com/zapprx.
Media Contact:
Heath Umbach
Sr. Director of Marketing and Business Development
[email protected]
617.844.0989
SOURCE ZappRx
Share this article